Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Ablacon
Cortex develops the OptiMap System, an AI-powered, 510(k) cleared electrographic flow mapping solution for diagnosing and treating atrial fibrillation (AF). The system uses a 64-electrode basket…
Ablacon
Cortex develops the OptiMap System, an AI-powered, 510(k) cleared electrographic flow mapping solution for diagnosing and treating atrial fibrillation (AF). The system uses a 64-electrode basket…
TL;DR
Founded: 2015
Headquarters: Wheat Ridge, Colorado, United States
Product: AI-powered electrographic flow mapping system for atrial fibrillation (OptiMap)
Regulatory status: 510(k) cleared (electrographic flow mapping solution)
Employees: 11–50
Last reported raise: Series B, Jan 7, 2021
Company Overview
Problem Domain
Diagnosis and treatment guidance for atrial fibrillation via electrographic mapping and AI analysis.
Founded
2015
Industry
Medical technology; cardiac electrophysiology
Funding Track Record
Investor Signal
“Investors include Zeus Health, Western Technology Investment (WTI), and Ajax Health”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,300+
New This Week